Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Torti

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Revista Clinica Espanola|March 18, 2004
HIV-associated asymmetric lipodystrophy syndromeE Quiros-Roldan, F Moretti, C Torti, et al.
Pediatric Dermatology|March 5, 2011
Spitz nevi arising in speckled lentiginous nevus: clinical, histologic, and molecular evaluation of two casesDorothea C Torti, Jeoffry B Brennick, Craig A Storm, et al.
HIV Medicine|October 4, 2003
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patientsY Gilleece, C Torti, S Mandalia, et al.
Infection|June 6, 2003
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospitalE Quiros-Roldan, F Moretti, C Torti, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infectionP Airò, C Torti, M C Uccelli, et al.
Journal of Clinical Laboratory Analysis|February 15, 2001
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapyE Quiros-Roldan, S Signorini, F Castelli, et al.
Sexually Transmitted Infections|April 12, 2003
Polymorphic immune restoration syndrome after effective HAARTE Quiros-Roldan, C Torti, S Casari, et al.
Microbios|August 17, 2001
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatmentE Quiros-Roldan, D Bertelli, S Signorini, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2020
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumabL Rapisarda, P Valentino, S Barone, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Revista Clinica Espanola|March 18, 2004
HIV-associated asymmetric lipodystrophy syndromeE Quiros-Roldan, F Moretti, C Torti, et al.
Pediatric Dermatology|March 5, 2011
Spitz nevi arising in speckled lentiginous nevus: clinical, histologic, and molecular evaluation of two casesDorothea C Torti, Jeoffry B Brennick, Craig A Storm, et al.
HIV Medicine|October 4, 2003
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patientsY Gilleece, C Torti, S Mandalia, et al.
Infection|June 6, 2003
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospitalE Quiros-Roldan, F Moretti, C Torti, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infectionP Airò, C Torti, M C Uccelli, et al.
Journal of Clinical Laboratory Analysis|February 15, 2001
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapyE Quiros-Roldan, S Signorini, F Castelli, et al.
Sexually Transmitted Infections|April 12, 2003
Polymorphic immune restoration syndrome after effective HAARTE Quiros-Roldan, C Torti, S Casari, et al.
Microbios|August 17, 2001
HIV-1 multi-dideoxynucleoside resistance mutation (Q151M): prevalence, associated resistance mutations and response to antiretroviral salvage treatmentE Quiros-Roldan, D Bertelli, S Signorini, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Clinical Immunology (Orlando, Fla.)|August 11, 2020
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumabL Rapisarda, P Valentino, S Barone, et al.
Pageof 9